Morris Charles Q

Morris Charles Q is listed in filings as Chief Medical Officer at Prelude Therapeutics Incorporated. This profile follows SEC Form 4 activity through May 4, 2026, including 2 public disclosures. Recent filings connect the profile to Prelude Therapeutics Incorporated (PRLD) and LAVA Therapeutics N.V. (LVTX). The current snapshot covers public activity from Feb 18, 2025 to May 4, 2026. Reported amounts are shown as $2.1M to $121.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.